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Abstract
Live bacteria (such as probiotics) have long been used to modulate gut microbiota and human physiology, but their colonization is mostly transient. Conceptual understanding of the ecological principles as they apply to exogenously introduced microbes in gut ecosystems is lacking. We find that, when orally administered to humans, Bifidobacterium longum
AH1206 stably persists in the gut of 30% of individuals for at least 6 months without causing gastrointestinal symptoms
or impacting the composition of the resident gut microbiota. AH1206 engraftment was associated with low abundance
of resident B. longum and underrepresentation of specific carbohydrate utilization genes in the pre-treatment microbiome. Thus, phylogenetic limiting and resource availability are two factors that control the niche opportunity for AH1206
colonization. These findings suggest that bacterial species and functional genes absent in the gut microbiome of individual humans can be reestablished, providing opportunities for precise and personalized microbiome reconstitution.
Introduction

survival rates in the gastrointestinal tract, but are subsequently
detectable for less than 2 weeks following cessation of intake
(Alander et al., 2001; Charbonneau et al., 2013; Firmesse et al.,
2008; Frese et al., 2012; Malinen et al., 2002; Rattanaprasert et al.,
2014; Rochet et al., 2008). In most studies, the introduction of a
live microbe did not result in significant alterations of the fecal
microbiota (Kristensen et al., 2016). Overall, the persistence and
ecological impacts of introducing live microbes in the human
gut appear limited, and fundamental questions remain regarding
the feasibility of establishing live microbes in the human gut and
the modulatation of the microbiome through such an approach.
The gastrointestinal tract and its microbiota constitute an interactive ecosystem in which spatial, temporal, and functional
characteristics are governed by the principles of community
ecology (Walter and Ley, 2011). The introduction of a microorganism into the gut ecosystem can be considered as a biological invasion of a non-native organism into a resident microbial community (Costello et al., 2012). Invasion ecology provides
a framework to study and understand the incursion of a foreign species into an established community (Shea and Chesson, 2002). Several questions addressed in the field directly

The human gut microbiota makes critical contributions to host
health (Fukuda et al., 2011; Round and Mazmanian, 2009). However, it has also become increasingly clear that several systemic
diseases are associated with aberrations in gut microbiota composition often referred to as ‘‘dysbiosis’’ (Walker and Lawley,
2013). Although few cause-and-effect relationships have been
established in humans, strong associations between gut microbiota composition and various pathologies provide a compelling case for the development of strategies that target the gut
microbiota and, ideally, reverse dysbiotic patterns (Olle, 2013).
One of the strategies used to modulate the gut microbiota
is by dietary administration of live microorganisms, often referred to as probiotics (Hill et al., 2014) or live biotherapeutics
(Olle, 2013). There is substantial literature published on the use
of lactic acid bacteria in human clinical trials, many of which reported beneficial effects (Ceapa et al., 2013). However, the degree to which clinical improvements have been causally linked
to probiotic- induced microbiota changes has not been established (Sanders et al., 2013). Moreover, most strains show high
515
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apply to the application of probiotics and live biotherapeutics.
Which traits make a species a successful invader or colonizer?
What features of an ecosystem determine their susceptibility
to invasions? What is the ecological impact? Although invasion
ecology currently lacks a unifying theory that addresses these
questions (Guo et al., 2015), it provides a useful framework for
understanding probiotic functionality and impact and ultimately
may advance their application. For example, according to theory,
specific traits that overcome the environmental filters of the ecosystem are required for biological invasions (Mächler and Altermatt, 2012; Olyarnik et al., 2009). The inability of commercial probiotic strains to persist in the human gut might therefore stem
from the absence of key adaptations necessary to successfully
compete in this ecosystem. This might be because most probiotic strains currently used belong to bacterial taxa (e.g., Lactobacillus species, Bifidobacterium animalis subsp. lactis, etc.) that
are allochthonous to the human gastrointestinal tract (Biavati
and Mattarelli, 2012; Walter, 2008). There is clearly a knowledge
gap regarding how dominant autochthonous members of the
gut microbiota would perform ecologically, both in terms of persistence as well as their impact on the resident microbiota, after
being introduced into the human gut.
The goal of this study was to systematically assess the ecological role and impact of a bacterial species autochthonous to
the human intestinal tract when administered to human individuals, applying a framework based on invasion ecology theory. We selected a strain of Bifidobacterium longum, a bacterial
species known to be a core member of the human gastrointestinal microbiota that forms stable and numerically dominant
populations in most individuals (Martínez et al., 2013; Schloissnig et al., 2013; Turroni et al., 2009). We conducted a doubleblinded, crossover, placebo-controlled trial in healthy humans
aimed at (1) assessing how long a highly adapted bacterium
can be established in the human gastrointestinal tract, (2) determining the impact of this administration on the resident
bacterial community, (3) determining the effect of this strain
on gastrointestinal symptoms of the subjects, and (4) identifying the precise community features of the resident microbiome that determine colonization.
Results
Introduction of B. longum AH1206 into the Digestive Tract
of Humans
We performed a human crossover trial in which 23 subjects consumed a daily dose of 1010 viable cells of B. longum subsp.
longum AH1206 or a placebo (maltodextrin) in random succession, with 38 or 46 days washout between treatments (Figure
1A). Fecal samples were collected at baseline, days 7 and 14 of
the treatment period, and 4, 8, 15, and 28 days after completion of each treatment for ‘‘test of persistence’’ (TOP). From fresh
fecal samples, total bifidobacteria were quantitatively cultured,
and 30 randomly picked colonies per subject at baseline and 14
days of treatment were typed by strain-specific PCR. As shown in
Figure 1B, this analysis revealed that the test strain was detectable at around 7.4 ± 1.2 log10 viable cells/gram of feces during
AH1206 treatment period, but not during the baseline or placebo periods (samples that showed a carry-over effect were excluded), indicating survival of AH1206 during transit through the
gastrointestinal tract. No adverse effects were detected during

consumption of AH1206 as determined by a standardized questionnaire for gastrointestinal symptoms (Figure S1).
B. longum AH1206 Colonizes the Gut of a Subset of Individuals for Extended Periods of Time
Three independent approaches were used to test for AH1206
persistence. Quantification in fecal samples via strain-specific
quantitative real-time PCR (qPCR) revealed that the strain was
undetectable (<104 cells per gram) prior to treatment in all but
one subject (this subject was therefore removed from further
analysis). The strain became detectable in all subjects during
the treatment period and reached an average population of
7.7 ± 0.9 and 7.6 ± 0.8 log10 cells/gram of feces after 1 and 2
weeks of administration, respectively (Figure 1C). The average
levels of AH1206 decreased after cessation of consumption, but
remained significantly elevated 28 days after treatment compared to the pre-treatment baseline (p < 0.05) (Figure 1C). In
addition, AH1206 remained detectable in three subjects during the baseline and placebo phases of the second test period, suggesting the strain could persist in a subset of subjects
beyond 28 days after being consumed. To test for long-term
persistence of AH1206, we collected fecal samples at 11 and
20 weeks after completion of the trial. This analysis revealed
that AH1206 abundance was still significantly elevated in the
20 week follow-up samples compared to pre-treatment baseline levels (Figure 1C). When assessing AH1206 levels among all
subjects in an individual basis, it became clear that there was a
substantial degree of inter-personal variability in the levels of
persistence (Figure 1D). In 14 subjects (64%), the strain became
undetectable between day 4 and 28 of washout. However, in
eight subjects (36%) the strain remained present at levels between 106 and 1010 (average 7.43 ± 1.33 log10) cells per gram
of feces >88 days and in seven subjects (27%) for >166 days
after consumption cessation.
To determine persistence of AH1206 using an approach not reliant on the detection of a single marker gene, we sequenced
the genome of B. longum AH1206 and identified genes of this
strain that were absent in the combined pre-treatment (baseline) microbiomes of all participants. This was done by mapping
metagenomic reads against the AH1206 genome and considering only matches with 100% homology. This analysis identified
26 genes specific to AH1206. We then determined the abundance of these genes in samples collected pre-treatment, after
14 days of probiotic consumption, and around 200 days after
consumption by mapping the metagenomics sequence reads
against the AH1206-specific genes. Most of the genes became
detectable during treatment (p < 0.0001 for all subjects) and remained significantly higher for persisters after treatment cessation (p = 0.0313 for all subjects baseline versus ~200 days TOP),
while they disappeared in most non-persisters (p = 0.2500 baseline versus ~200 days TOP) (Figure 2A). These results demonstrate that a set of genes unique to AH1206 remained detectable in persisters for around 200 days after consumption of the
strain, confirming long-term persistence.
To determine if AH1206 could be recovered after prolonged
colonization periods, we selectively cultured bifidobacteria from
fecal samples of persisters collected after 20 weeks and typed 30
random colonies per subject by strain-specific PCR. Isolates that
typed as AH1206 were recovered from four subjects. Of those,
five random isolates per individual were then typed by multilocus
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Figure 1. Experimental Design and Survival and Persistence of B. longum Subsp. longum AH1206 in the Human Gut
(A) Experimental design of the human trial. The arrows indicate the collection of fecal samples, completion of Gastrointestinal Symptom Rating Scale
(GSRS) forms, and samples that were sequenced and used for typing of isolates.
(B) Proportions of strain AH1206 among the total cultured bifidobacteria during the two baseline periods, treatment, and placebo as determined by
colony PCR with strain-specific primers. The groups labeled with different letters are significantly different (repeated-measures two-way ANOVA;
a = 0.05, p < 0.0001).
(C) Quantification of B. longum AH1206 in fecal samples by strain-specific qPCR. The data are represented as mean and SE. Baseline: BL. The significant difference between time points and baseline are indicated by asterisks. Repeated-measures two-way ANOVA with Dunnett’s multiple comparison; ***p < 0.001; **p % 0.01; and *p % 0.05.
(D) Cell numbers of B. longum AH1206 in fecal samples determined by qPCR throughout the entire trial with subjects categorized as persisters (closed
symbols) and non-persisters (open symbols).

sequence analysis (MLSA). This analysis showed that all isolates
belonged to the species B. longum, and for three subjects, the
isolates displayed the same sequence type as AH1206 (i.e., the
sequences of all seven housekeeping genes were identical) (Table S1). These findings demonstrated that, despite the difficulty
to detect a particular strain by culture among the resident cultivable Bifidobacterium population of around 109 cells per gram,
AH1206 could be recovered from three individuals around 200
days after being administered.
Overall, the results clearly demonstrate that AH1206 can colonize the human gut in high numbers for prolonged periods of
time in a subset of individuals. We refer to this subset of individuals as ‘‘persisters’’, while those who did not permit colonization are named ‘‘non-persisters’’. Persistence was at least 166
days for seven subjects, but in one subject, (J), AH1206 became
undetectable in the first follow-up sample, which coincided with
the use of a prescribed laxative product containing antimicrobial
components. Since this subject completed the entire crossover
trial and showed persistence of AH1206 for 88 days, which was
substantially longer than persistence in non-persisters (max. 28

days; Figure 1D), this subject was considered a persister. It was
therefore included for analyses that compared microbiome at
baseline and during treatments, but excluded from the analyses
of the microbiome of the 20 week follow-up sample.
Administration of AH1206 Does Not Alter the Taxonomic
Composition of the Fecal Microbiota
Illumina sequencing of 16S rRNA gene tags (V5–V6 region) revealed that administration of AH1206 did not change the structure of the overall bacterial communities of the fecal microbiota
(Adonis permutational multivariate ANOVA [PERMANOVA], p =
0.999) and proportions of specific members, including Bifidobacterium species (Figures S2A–S2E). In addition, a-diversity was
not altered by either treatment (data not shown). Compositional
analysis by whole-metagenome sequencing (WMS) confirmed
the lack of impact of AH1206 on the taxonomical composition of
the fecal microbiota (Figure S2A). However, the functional analysis revealed a significant increase of 29 genes during consumption of AH1206 (Figure 2B; Table S2). Remarkably, all these genes
were assigned to the species B. longum and have more than 98%
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Figure 2. WMS Analysis Confirms Establishment and Persistence of AH1206
(A) Quantification of genes unique to B. longum AH1206 in fecal samples taken during pre-treatment baseline, consumption of the strain (14 days),
and around 200 days after consumption. Mean coverage for each AH1206-specific gene was obtained by mapping metagenomics sequence
reads against AH1206 specific genes absent in the combined pre-treatment metagenome. The bars represent the relative abundance (y axis) of
each of the 26 genes (x axis).
(B) Administration of AH1206 caused enrichment of a set of genes belonging to the species B. longum into the gut ecosystem. The relative abundances (mean coverage) before and during consumption are shown.

DNA identity to AH1206 genes (100% coverage). Therefore, although administration of AH1206 did not alter the taxonomic
composition of the fecal microbiota, it enriched for functional
genes belonging to the species B. longum.
Ecological Characteristics of the Resident Gut Microbiota
Are Not Major Determinants of Long-Term Persistence
Comparison of overall community configurations in persisters
and non-persisters at baseline using b-diversity values (BrayCurtis distances), NMDS plots, and Adonis PERMANOVA revealed no differences (p = 0.2488) (Figure 3A). Higher diversity has been associated with a lower invasion susceptibility of
a community, as higher species richness is likely to translate directly into higher diversity of functional traits, elevated resource
depletion, as well as an increased probability of competitive species to be present (Díaz and Cabido, 2001; Kennedy et al., 2002;
Mallon et al., 2015; Tilman, 2004). However, although trends were
observed, neither total a-diversity (p = 0.0759 for total operational taxonomic units [OTUs] and p = 0.2901 for Shannon diversity index) (Figure 3B) nor functional richness (p = 0.0759 and p
= 0.0818, for single and assembled reads, respectively, data not
shown) were significantly higher in non-persisters. Evenness has
also been described as a barrier to invasions (De Roy et al., 2013;
Wittebolle et al., 2009), but no differences were detected (p =
0.1423) (Figure 3C). In addition, disturbances have been shown
to facilitate invasion of non-native species (Elton, 1958; Kneitel

and Perrault, 2007). However, although higher stability was associated with resistance to short-term colonization of food-born
microbes in a rat model (Zhang et al., 2016), long-term colonization of AH1206 in humans was not linked to fecal microbiota
stability (p = 0.6087 for Morisita-Horn) (Figure 3D).
Community Membership Differs in Persisters and
Non-persisters
To determine possible competitive interactions of AH1206 with
specific members of the gut microbiota, we compared the composition of fecal bacterial communities at baseline (i.e., pre-treatment) to identify and rank taxa that discriminate persisters from
non-persisters using both Wilcoxon tests and random forest (RF)
analysis (Figure 3E). Results revealed that Coriobacteriaceae family (p = 0.0243, mean importance 2.5), Collinsella genus (p =
0.0169, mean importance 2.57), and Collinsella aerofaciens (OTU
1, p = 0.0357, mean importance 1.52) were reduced in persisters.
In contrast, Eggerthella (p = 0.0229, mean importance 3.30) and
Eggerthella lenta (OTU 52, p = 0.0497,mean importance 1.96)
were elevated in persisters (Figure S3B; Table S3). The most discriminative taxon, however, was the OTU that represented B.
longumOTU11,whichshowed a higher abundance in non-persisters (Wilcoxon test, p = 0.0022; random forest mean importance 6.12) (Figures 3A and S3C). Consistent findings were obtained with minimum entropy decomposition (MED) (p = 0.004)
and species-specific qPCR (p = 0.0367) (Figure S3C).
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Figure 3. Influence of Ecological Factors on AH1206 Invasibility of Baseline Fecal Microbial Communities (A) Overall comparison of community profiles between persisters and non-persisters revealed no significant differences (p = 0.2488; Adonis PERMANOVA). The data are shown by NMDS.
(B–D) a-diversity (B), evenness (C), and stability (D) of the fecal microbiota of persisters and non-persisters. Data in boxplots show the median,
first, and third quartiles (hinges); whiskers are extended to the highest value within the 1.5 3 IQR of the upper and lower hinges. (E and F) Barplots of the average abundance ratio of highly discriminant taxonomic groups (E) and B. longum genes (F) in pre-treatment samples in persisters and non-persisters. OTUs for which percentages of identity are not indicated have >99% identity to the type strain of the indicated bacterial
species. Mean importance and p values were determined by random forest analysis and Mann-Whitney-Wilcoxon test, respectively. Persister: P,
Non-Persister: NP.

The significantly higher proportions of fecal B. longum at
baseline in non-persisters suggest that colonization of AH1206
might be prevented by other strains within the same species.
Ecology theory predicts that competition would be stronger between phylogenetically related organisms as they share similar traits and therefore display a larger degree of niche overlap.
Accordingly, colonization would be prevented by competitive
exclusion (Hardin, 1960), a process collectively referred to as
phylogenetic limiting (Violle et al., 2011). To test for phylogenetic limiting, we quantified the proportion of 16S rRNA-gene
tag sequences from fecal samples obtained during pre-treatment baseline and the placebo periods that matched strain

AH1206 with decreasing levels of sequence similarity. This analysis revealed significantly higher proportions in non-persisters
at higher percent similarity (>97%), while at lower sequence similarities (93%–95%) differences became non-significant (Figure
S3D), suggesting that AH1206 colonization is prevented through
phylogenetic limiting.
The Microbiome of Persisters and Non-persisters Differs in
the Abundance of B. longum Genes
The findings described above indicated that baseline B. longum
abundance is inversely associated with persistence. However,
B. longum levels did not explain the findings in all subjects, in
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that some persisters had relatively high levels of B. longum. Because traits that define niches and competitive interactions are
not necessarily phylogenetically conserved in bacteria, and can
differ substantially within the same bacterial species (Zhu et
al., 2015), we used WMS data and compared the abundance of
genes identified to belong to the species B. longum, at pretreatment baseline between persisters and non-persisters. A Wilcoxon
test resulted in 70 genes with differential abundance between
persisters and non-persisters (Figure 3F; Table S4). These genes
comprised functions involved in metabolism, cellular processes,
and information storage and processing, with genes involved in
carbohydrate metabolism accounting for many of these functions (38% of the genes with assigned functions). Even though
multiple correction test (FDR) rejected all genes identified as significant, 93% of the discriminative genes and 100% of the genes
involved in carbohydrate metabolism were enriched in non-persisters, suggesting a clear pattern in the discriminant features.
Given the limited ability of classical hypothesis testing methods in identifying significant features from highly complex and
noisy data sets like microbiomes (Knights et al., 2011), we independently identified genes that discriminated persisters from
non-persisters using a random forest classifier. This analysis revealed that a total of 60 (90%) of the previously identified genes
had good discriminative power (mean importanceR0.01) (Table
S4). The 13 genes that best discriminate (mean importance > 1)
between persisters and non-persisters are shown in Figure 3F.
Consistent with the findings above, more than half of the genes
were involved in carbohydrate metabolism and all but one were
overrepresented in non-persisters.
To determine which taxonomic and gene-based microbiome
signatures are the best predictors of B. longum AH1206 colonization, all predictive features, taxonomic groups (Table S3), and
functional genes (Table S4) were ranked by random forest classifier based on AH1206 persistence. This analysis showed that,
overall, B. longum genes were better predictors of AH1206 persistence than bacterial taxa (Table S5). However, OTU 11 ranked
second, showing that this taxon has a strong predictive value.
To test specifically if genes are better predictors of invasion than
OTU 11 proportions, we compared independent linear models
regressing persistence against the OTU and a gene, respectively,
to a combined linear model, using ANOVA. This analysis revealed
that genes, 1830 (permeases of the major facilitator superfamily)
and 0877 (b-galactosidase ranked sixth), outperform B. longum
levels at predicting persistence of AH1206 (p < 0.0005 and p <
0.001 for 1830 and 0877, respectively).
Genes that Predict Colonization Show Inter-individual
Variation among the Resident B. longum Populations
The analyses above showed that although B. longum abundance
was identified as a significant predictor of invasibility, several B.
longum genes scored higher. In addition, the subject with the
highest population of B. longum (around 17% of total bacterial
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sequences at baseline pre-treatment) was a persister (subject
D), while several non-persisters harbored low proportions of B.
longum (Figure 4A). To determine whether this discrepancy could
be explained by inter-personal variation in gene abundance, we
selected six discriminant genes that were predicted to have a
key role in carbohydrate utilization and quantified their abundance by qPCR. This analysis revealed that at baseline, non-persisters that had relative low levels of resident B. longum still harbored, for the most part, comparable levels of these genes as
did non-persisters with higher levels of B. longum (Figure 4A).
In contrast, four of the discriminant genes were not detectable
in the outlier persister with high levels of native B. longum (subject D). This analysis suggests interindividual variability of genes
among the resident B. longum population, consistent with recent findings in several dominant species present in the human
gut (Zhu et al., 2015).
To address this variability from a genomic perspective, we analyzed gene coverage within the genomic regions (obtained after
metagenome assembly) that included the discriminative genes
in individual participants. Gene coverage of the entire gene-containing contigs revealed higher and consistent coverage for nonpersisters, reflecting the higher average levels of B. longum (Figure 4B). In contrast, the discriminative genes were absent in most
persisters, even those that showed a high degree of coverage in
the flanking regions (e.g., subject D). Overall, these findings indicate that genes that predict persistence are not phylogenetically conserved, as they were present in non-persisters with low
B. longum abundance and absent in most persisters with high B.
longum levels, with only one single exception (subject B).
Genes Predictive of Colonization Encode Functional Traits
that Constitute a Niche for AH1206
The underrepresentation of carbohydrate-utilization genes in
persisters might result in the availability of resources that constitute a vacant niche for AH1206. For this to apply, two conditions would have to be met. First, strain AH1206 would have to
possess the functional traits encoded by these genes to successfully occupy the niche, and second, the differences in the relative abundance of these genes in persisters and non-persisters
should disappear after the establishment of AH1206 as a consequence of the strain occupying the niche.
To determine if both conditions apply, we first determined if
the genes that were shown to discriminate persisters from nonpersisters (Table S4) were present in AH1206. A total of 65 out
of the 70 discriminate genes (93%) had homologs (amino-acid
similarity >98%, 100% coverage) in the genome of AH1206, suggesting that this strain indeed possesses most of the traits necessary to occupy the vacant niche. Second, to test if the niche
becomes occupied after AH1206 is established, we conducted an
NMDS analysis using the mean coverage (based on WMS data)
of the 70 discriminative genes of persisters and non-persisters
at baseline. This analysis revealed that while baseline samples

Figure 4. Abundance of Representative Discriminatory Genes in Individual Subjects (A) Absolute abundance of representative genes that predict colonization as quantified by qPCR of persisters with high levels and non-persisters with low levels of B. longum. The average and SE of the absolute abundance of genes in all subjects is also shown. (B) Relative abundance represented as the mean coverage of the WMS reads within representative genomic regions containing genes that predict persistence. The shaded areas display the genes of interest.
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Figure 5. Differences in Gene Distribution in Persisters and Non-persisters Disappear after Engraftment of B. longum AH1206 NMDS plots based on
Bray-Curtis distance calculated with the abundance of 70 genes that differ in persisters and non-persisters. Baseline (A), probiotic treatment (B),
and around 200 days TOP (C). Boxplots showing average gene abundance for genes g 2015, Lacl-type response repressor (D); g 1077, Lacl-family transcriptional regulator (E); g 1467, (F), and g 1830, permeases of the major facilitator superfamily (COG0477) (G); g 1136, ABC-type sugar
transport system permease component (H); and g 0877, b-galactosidase (I). Means and SEM are shown. Wilcoxon test; **p % 0.01; *p % 0.05;
and not significant: n.s.

of persisters and non-persisters clustered separately (Figure 5A)
(Adonis PERMANOVA, p = 0.005), the clustering disappeared
during AH1206 consumption (Figure 5B) and ~200 days after
consumption (Figure 5C) (Adonis PERMANOVA, p = 0.2736 and
p = 0.3383), respectively. In addition, individual carbohydrateutilization genes showed significant differences in abundance
at baseline, yet these differences disappeared during establishment and persistence of AH1206 (Figures 5D–5I). We confirmed

quantification of the six genes with key roles in carbohydrate utilization by qPCR. This analysis revealed that the significant differences in abundance of five out of the six genes detected at
baseline between persisters and non-persisters disappeared after AH1206 was established (Figure S4). Overall, these findings
support the hypothesis that the genes that are underrepresented
in persisters encode traits that reflect an open niche, allowing
AH1206 to stably colonize.

Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut
Discussion
In this study, we applied a conceptual framework based on invasion ecology to reveal insights into how an autochthonous
member of the human gut microbiota colonizes the human
gastrointestinal tract, the ecological characteristics of the resident microbiome that influence colonization, and the implications that arise from colonization for both the microbiome and
the host. By using a combination of complementary methods,
we demonstrated stable persistence of B. longum AH1206 in a
subset of subjects dependent on individualized features of the
resident gut microbiome likely related to variations in the existence of an open niche. One central focus of invasion ecology is the determination of the ecological impact that invasive
species have on an ecosystem (Simberloff et al., 2013). This is
relevant for the application of probiotics and live biotherapeutics as their effect on the resident microbiota could range from
beneficial to detrimental. Our study clearly established that administration of AH1206 neither resulted in changes to the resident microbiome nor detectable adverse effects (gastrointestinal
symptoms) for the human hosts. Based on these findings, and in
accordance to proposed invasion ecology nomenclature (Davis
and Thompson, 2000), we argue that the long-term establishment of AH1206 qualifies this organism as a colonizer and not
as an invader. Here, we propose the term ‘‘engraftment’’, which
refers in general terms to an ‘‘incorporation in a firm or permanent way’’ (Dictionaries, 2014), and in medical terms, to an ‘‘incorporation of grafted tissue into the body of the host’’ (Miller
et al., 2005), as the term to refer to the stable establishment of
a bacterial strain in the human gut.
The findings of long-term persistence of AH1206 contrast
with those from a vast majority of studies with live microbes that
show limited persistence. Interestingly, the only other study to
our knowledge that established long-term persistence of an ingested strain in a subset of participants using a strictly strainspecific approach also utilized a strain of B. longum (Fujiwara et
al., 2001). Together, these findings suggest that autochthonous
core members of the human gut microbiome may display elevated levels of persistence when compared to allochthonous
species currently used in commercial probiotic products. However, it remains unclear whether the ability of stable engraftment
is a more general attribute of autochthonous gut microbes or
rather is a particular attribute of specific strains of B. longum.
Next-generation probiotics and live biotherapeutics based on
core members of the gut microbiome (e.g., those that are underrepresented in dysbioses) are currently being developed (Olle,
2013). The findings obtained in this study are therefore directly
relevant for the development of microbiometargeted strategies
as they suggest that an autochthonous bacterial strain may have
a higher ecological fitness when administered to humans than
allochthonous strains. Although it is not yet known if ecological performance relates to increased probiotic functionality, the
findings warrant future research on the health effects on autochthonous gut microbes.
This study identified a strong and statistically significant
phylogenetic signal associated with colonization of AH1206,
showing that establishment was prevented, likely through competitive exclusion, in the presence of phylogenetically related
organisms within the resident microbiome. Therefore, our findings support Darwin’s naturalization hypothesis that states that
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introduced species are more successful at surviving in communities in which their close relatives are absent (Darwin, 1859).
In contrast, Li et al. (2016) showed that bacterial strains introduced through fecal transplants are more likely to be established in the recipient human if the species are already present. Similarly, Stecher et al. (2010) suggested a ‘‘like will to like’’
rule in that colonization of both pathogens and commensals
in the murine gut is favored by the presence of related species. Inconsistencies regarding the role of phylogenetic relatedness in colonization success have been observed in other
ecosystems and have been attributed to the notion that phylogenetic patterns of community assembly are often scale dependent and confounded by extrinsic factors such as fluctuations in environmental conditions (Li et al., 2015; Proches et
al., 2008; Thuiller et al., 2010). In this respect, it is important to
recognize that environmental filtering (selection for phylogenetically related members that share traits that enable colonization) and competitive exclusion (selection for phylogenetically distinct members with different traits that result in niche
differences) act together in ecosystems (Mayfield and Levine,
2010). The processes that determine which species co-exist and
assemble within gut microbial ecosystems are therefore likely
to be context, scale, and taxon dependent.
Although our findings indicate competitive exclusion of
AH1206 by the resident B. longum population, exceptions existed where either persisters harbored high populations of B.
longum or non-persisters had low levels of it. In this respect, it
has to be noted that functional traits (including those that define niches) are not necessarily evolutionarily conserved in bacteria (Shafquat et al., 2014). This can directly influence the degree
by which phylogenetic relatedness conveys competitive interactions among members of the human gut microbiome. Most bacterial species, including B. longum, possess pan-genomes with
individual strains displaying variation in genomic content (Chaplin et al., 2015; O’Callaghan et al., 2015). Horizontal gene transfer can further lead to similar genetic information being shared
among bacterial taxa that are not closely related, resulting in
phylogenetically distant taxa with similar traits (Boto, 2010). Our
trait-based analysis demonstrated that specific functional genes
of the species B. longum are better predictors of engraftment
when compared to B. longum itself. It appears that the niche of
AH1206 is occupied by B. longum in most non-persisters, although exceptions exist in which it is either not occupied by B.
longum in persisters (through interspecies genetic variability) or
is occupied by other taxa in nonpersisters (through HGT). There
was only one exception in our study that did not concur with
this explanation (subject B), a persister harboring both high levels of B. longum and discriminative genes (Figure 4). We speculate that persistence in this individual might have been caused
by AH1206 being able to compete with the resident strain(s),
which is supported by a metagenomics analysis of single nucleotide variations that suggests that AH1206 co-exists with native
members of B. longum (data not shown).
The majority of the genes that discriminated the pre-treatment microbiome of non-persisters from persisters were underrepresented in persisters and involved in carbohydrate utilization. This finding suggested that the establishment of AH1206
was dependent on resource availability, or accordingly, a niche
opportunity (Shea and Chesson, 2002). Some of the genes encode for b-galactosidases and LacI-type regulatory proteins,
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indicating that galactose-containing substrates, which have been
shown to contribute to the nutritional niche of bifidobacteria in
the human gut (Davis et al., 2011; O’Connell et al., 2013), contribute to the colonization success of AH1206. Accordingly, homologs of the discriminative genes g0877 and g2015 are present
in gene clusters of AH1206 that are highly conserved in Bifidobacterium breve (Figure S5). These particular regions have been
functionally characterized in B. breve to be involved in the utilization of the plant-derived carbohydrates galactan and melezitose, respectively (O’Connell Motherway et al., 2011; O’Connell
et al., 2014). It is therefore possible that the variation of dietary
habits (not assessed during this study) might have contributed
to the individual differences in AH1206 colonization. Overall, the
findings support the theoretical framework proposed by Mallon
et al. (2015), which postulates that resistance of microbial communities to invasion is linked to resource depletion. However, engraftment of AH1206 appears to be less dependent on species
richness and evenness and more on the presence of community members that are functionally similar to AH1206. Our findings are in complete agreement with mechanistic studies in mice
showing that colonization of Bacteroides strains was prevented
only by members of the same species and driven by competition
for specific carbohydrates (Lee et al., 2013). Deletion of a polysaccharide utilization locus in Bacteroides fragilis reduced competitive exclusion and allowed colonization of a second strain.
These findings provide an explanation for why the persisters with
high baseline B. longum levels in our study may still allow engraftment of AH1206 if the resident strains lack specific carbohydrate-utilization genes.
Overall, the findings of this study suggest that specific core
members of the gut microbiome and functional genes associated with them can be established in humans in which they
are absent. This important discovery could provide a basis for
precision microbiome reconstitution to redress specific dysbiotic patterns. In addition, this study provides an early demonstration for how engraftment of a bacterial strain can be predicted based on microbiome features. Such predictions could
be applied to personalize the use of probiotics and live biotherapeutics to increase their beneficial value. More extensive
human studies with autochthonous bacterial strains are warranted to establish their health benefits, develop and validate
reliable predictive models, and test the potential to personalize
such approaches based on these models. Moreover, the ability of a probiotic strain to persist when specific niche-defining
resources are available reinforces the potential of the symbiotic concept (Kolida and Gibson, 2011). If systematically developed based on ecological criteria (Krumbeck et al., 2015), synbiotics could ensure the provision of growth substrates (in the
form of dietary carbohydrates or prebiotics) that enable longterm persistence of probiotic strains.
Experimental Procedures
The human trial was approved by the Institutional Review Board of the
University of Nebraska (IRB Approval Number: 222-12-FB) and registered
in Clinical Trials web page (Identifier: NCT01650753). Written informed
consent was obtained from all subjects.
Experimental Design
A double-blind, placebo-controlled, human crossover study with two

7-week test periods (including a baseline, a 14-day treatment, and a
28-day TOP) in 24 healthy human subjects (22 and 38 years of age) was
conducted with the primary objective to determine acceptability and
safety of B. longum subsp. longum AH1206 at a daily dose of 1010 cells
(Figure 1A). In total, 16 fecal samples were collected from every subject
for selective culture of bifidobacteria (for strain typing of bacterial isolates) and DNA isolation (for sequencing and qPCR). To evaluate tolerance of AH1206 intake, subjects provided weekly reports of gastrointestinal symptoms as described previously (Rattanaprasert et al., 2014).
Detailed information about the experimental design, bacterial culture
and strain typing, and DNA isolation is provided in the Supplemental
Experimental Procedures.
Quantification of Strain AH1206 and the Species B. longum by qPCR
B. longum AH1206 was quantified in fecal DNA by qPCR using a strainspecific primers and probe system (probe #89; Roche, Universal ProbeLibrary). Bifidobacterium longum was quantified by qPCR with species-specific primers. Details about the PCR program, primers, and
validation of the PCR system can be found in the Supplemental Experimental Procedures.
Sequencing of 16S rRNA Gene Tags and WMS
The fecal microbiota in samples collected during the baseline (of AH1206
treatment period), the last day of AH1206 consumption, the last day of
placebo consumption, and 28 days of TOP was characterized by nextgeneration sequencing as described by Krumbeck et al. (2015). WMS was
performed with fecal samples obtained during baseline, the last day of
consumption of the probiotic, and the 20 week follow-up sample using
the Illumina HiSeq 2500 platform. The accession number for the raw sequences reported in this paper is NCBI SRA: PRJNA324129. The software
Anvi’o (Eren et al., 2015) was used to generate, visualize, and quantify
genomic bins in the metagenomic data set. See Supplemental Experimental Procedures for details on sequencing and a description of the
bioinformatics analysis.
Ecosystem Characteristics
Measurements of a- and b-diversity as well as community evenness were
calculated using QIIME tools v 1.8.0 (Caporaso et al., 2011). b-diversity
measurements were used to assess temporal stability of an individual’s
fecal microbiota as the average of the distance between all consecutive
time points. Bray-Curtis distances between samples were calculated and
visualized in by non-metric multidimensional scaling (NMDS). See Supplemental Experimental Procedures for details.
Absolute Quantification of Functional Genes by qPCR
To confirm findings obtained with the metagenomics analysis, qPCR systems were developed for representative genes discriminant between persisters and non-persisters (see Supplemental Experimental Procedures).
Statistical Methods
Repeated-measures two-way ANOVAs with Bonferroni correction, repeated measures one-way ANOVAs, and Friedman tests were used to
determine the effect of treatment on microbiota taxonomic and functional composition and diversity measurements. Mann-Whitney-Wilcoxon tests were used to conduct pairwise comparisons between time
points and compare bacterial and gene abundances, a-diversity, stability, evenness, and functional richness between persisters and non-persisters. Permutational multivariate ANOVA (Adonis PERMANOVA with
200 permutations) based on sample distances (b-diversity) was used to
test for changes in the community composition. In order to identify discriminative independent variables, generate predictive models, and compare their performance, and compare the importance of variables that
predict the persistence of AH1206, random-forest analysis and ANOVA
tests were used. See the Supplemental Experimental Procedures for detailed descriptions of the statistical methods.

Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut
Accession Numbers
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Supplemental Information Supplemental Information includes Supplemental Experimental Procedures, five figures, and five tables and
can be found with this article online at http:// dx.doi.org/10.1016/j.
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